UPLC-MS/MS assay for quantification of an inhibitor of kinases (Foretinib) in plasma: Application to a pharmacokinetic study in rats
Foretinib, an oral multikinase inhibitor, is known to have anti-tumor effects against cancers. The doses and the levels of foretinib vary based on the type of cancer to be treated. An accurate and precise method is required to determine the level of foretinib and its pharmacokinetics. Here, we devel...
Saved in:
Main Authors: | Essam Ezzeldin (Author), Muzaffar Iqbal (Author), Yousif A. Asiri (Author), Azza A. Ali (Author), Toqa El Nahhas (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
by: Igor A. Zupanets, et al.
Published: (2019) -
Validated UPLC-MS/MS method for quantification of fruquintinib in rat plasma and its application to pharmacokinetic study
by: Mei YB, et al.
Published: (2019) -
Development of a robust UPLC-MS/MS method for the quantification of riluzole in human plasma and its application in pharmacokinetics
by: Zhuo Sun, et al.
Published: (2023) -
Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC-MS/MS
by: Shiva Kumar Gudlawar, et al.
Published: (2017) -
Development and validation of a rapid, simple, and reliable UPLC-MS/MS method for the quantification of vancomycin in human plasma
by: Tho Do Chau Minh Vinh, et al.
Published: (2024)